↓ Skip to main content

Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis

Overview of attention for article published in Arthritis Research & Therapy, September 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users

Citations

dimensions_citation
86 Dimensions

Readers on

mendeley
74 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis
Published in
Arthritis Research & Therapy, September 2014
DOI 10.1186/s13075-014-0427-y
Pubmed ID
Authors

Toshihiro Nagai, Masato Sato, Miyuki Kobayashi, Munetaka Yokoyama, Yoshiki Tani, Joji Mochida

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 74 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Italy 1 1%
Unknown 73 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 16%
Student > Ph. D. Student 10 14%
Student > Master 10 14%
Other 7 9%
Student > Bachelor 6 8%
Other 11 15%
Unknown 18 24%
Readers by discipline Count As %
Medicine and Dentistry 17 23%
Biochemistry, Genetics and Molecular Biology 11 15%
Agricultural and Biological Sciences 10 14%
Engineering 4 5%
Immunology and Microbiology 3 4%
Other 9 12%
Unknown 20 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 October 2014.
All research outputs
#15,810,483
of 26,017,215 outputs
Outputs from Arthritis Research & Therapy
#2,256
of 3,444 outputs
Outputs of similar age
#133,678
of 262,468 outputs
Outputs of similar age from Arthritis Research & Therapy
#27
of 50 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,444 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one is in the 32nd percentile – i.e., 32% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 262,468 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 50 others from the same source and published within six weeks on either side of this one. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.